Emran Parveen And Sons Vascular Access Center, Indialantic, FL - 32903

Emran Parveen And Sons Vascular Access Center, is categorized under Unclassified in Indialantic, FL and active since 2007.

Emran Parveen And Sons Vascular Access Center, was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Unclassified business, which does work in the B2B market, and is classified as a Unclassified, under code number 561990 by the NAICS.

If you are seeking more information, feel free to contact Emran Imami at the company’s single location by writing to 375 Ocean Oaks Drive, Indialantic, Florida FL 32903 or by phoning (321) 409-0033. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Emran Parveen And Sons Vascular Access Center,
Contact Person: Emran Imami
Address: 375 Ocean Oaks Drive, Indialantic, Florida 32903
Phone Number: (321) 409-0033
Annual Revenue (USD): $100.000 to $499.999
Founded: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Unclassified
SIC Code: 7389
NAICS Code: 561990
Share This Business:

Emran Parveen And Sons Vascular Access Center, was started in 2007 to provide professional Unclassified under the SIC code 7389 and NAICS code 561990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Emran Imami for inquiries that concern Emran Parveen And Sons Vascular Access Center, by calling the company number (321) 409-0033, as your correspondence is most welcome. Additionally, the physical location of the single location of Emran Parveen And Sons Vascular Access Center, can be found at the coordinates 28.108113,-80.577356 as well as the street address 375 Ocean Oaks Drive in Indialantic, Florida 32903.

For its online presence, you may visit Emran Parveen And Sons Vascular Access Center,’s website at and engage with its social media outlets through on Twitter and on Facebook.